CD28（抗体）の世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global CD28(Antibody) Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D005-00165 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、CD28（抗体）の世界市場を広く調査・分析し、今後の市場展望をまとめております。CD28（抗体）の種類別市場規模（90％以上、95％以上、99％以上、その他）、用途別市場規模（バイオ製薬会社、病院、バイオサイエンス研究機関、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbexa Ltd(UK)、Lifespan Biosciences(US)、Biobyt(UK)、Aviva Systems Biology Corporation(US)、BioLegend(US)、Boster Biological Technology(US)、Novus Biologicals(US)、Bioss Antibodies(US)、Bio-Rad(US)、ProteoGenix(FR)、USBiological(US)、Rockland(US)、ProSci(US)、St John's Laboratory Ltd(UK)、BethylLaboratories(US)、Thermo Fisher Scientific(US)、ProteoGenix(FR)、SouthernBiotech(US)、Genetex(US)、R&D Systems(US)、Atlas Antibodies(SE)、BioVision(US) ・地域別グローバル市場分析 2015年-2020年 ・CD28（抗体）の北米市場（アメリカ、カナダ、メキシコ） ・CD28（抗体）のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・CD28（抗体）のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・CD28（抗体）の南米市場（ブラジル、アルゼンチン） ・CD28（抗体）の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：90％以上、95％以上、99％以上、その他 ・用途別分析：バイオ製薬会社、病院、バイオサイエンス研究機関、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論

Market Overview
The global CD28(Antibody) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The CD28(Antibody) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
CD28(Antibody) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, CD28(Antibody) market has been segmented into:
Above 90%
Above 95%
Above 99%
Others

By Application, CD28(Antibody) has been segmented into:
Biopharmaceutical Companies
Hospitals
Bioscience Research Institutions
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global CD28(Antibody) market presented in the report. This section sheds light on the sales growth of different regional and country-level CD28(Antibody) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global CD28(Antibody) market.

The report offers in-depth assessment of the growth and other aspects of the CD28(Antibody) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and CD28(Antibody) Market Share Analysis
CD28(Antibody) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, CD28(Antibody) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the CD28(Antibody) sales, revenue and market share for each player covered in this report.

The major players covered in CD28(Antibody) are:
Abbexa Ltd(UK)
Lifespan Biosciences(US)
Biobyt(UK)
Aviva Systems Biology Corporation(US)
BioLegend(US)
Boster Biological Technology(US)
Novus Biologicals(US)
Bioss Antibodies(US)
Bio-Rad(US)
ProteoGenix(FR)
USBiological(US)
Rockland(US)
ProSci(US)
St John’s Laboratory Ltd(UK)
BethylLaboratories(US)
Thermo Fisher Scientific(US)
ProteoGenix(FR)
SouthernBiotech(US)
Genetex(US)
R&D Systems(US)
Atlas Antibodies(SE)
BioVision(US)

レポート目次

---

Table of Contents

1 CD28(Antibody) Market Overview
1.1 Product Overview and Scope of CD28(Antibody)
1.2 Classification of CD28(Antibody) by Type
1.2.1 Global CD28(Antibody) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global CD28(Antibody) Revenue Market Share by Type in 2019
1.2.3 Above 90%
1.2.4 Above 95%
1.2.5 Above 99%
1.2.6 Others
1.3 Global CD28(Antibody) Market by Application
1.3.1 Overview: Global CD28(Antibody) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Biopharmaceutical Companies
1.3.3 Hospitals
1.3.4 Bioscience Research Institutions
1.3.5 Others
1.4 Global CD28(Antibody) Market by Regions
1.4.1 Global CD28(Antibody) Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of CD28(Antibody) (2015-2025)
1.4.3 North America (USA, Canada and Mexico) CD28(Antibody) Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) CD28(Antibody) Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) CD28(Antibody) Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) CD28(Antibody) Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) CD28(Antibody) Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbexa Ltd(UK)
2.1.1 Abbexa Ltd(UK) Details
2.1.2 Abbexa Ltd(UK) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbexa Ltd(UK) SWOT Analysis
2.1.4 Abbexa Ltd(UK) Product and Services
2.1.5 Abbexa Ltd(UK) CD28(Antibody) Revenue, Gross Margin and Market Share (2018-2019)
2.2 Lifespan Biosciences(US)
2.2.1 Lifespan Biosciences(US) Details
2.2.2 Lifespan Biosciences(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Lifespan Biosciences(US) SWOT Analysis
2.2.4 Lifespan Biosciences(US) Product and Services
2.2.5 Lifespan Biosciences(US) CD28(Antibody) Revenue, Gross Margin and Market Share (2018-2019)
2.3 Biobyt(UK)
2.3.1 Biobyt(UK) Details
2.3.2 Biobyt(UK) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Biobyt(UK) SWOT Analysis
2.3.4 Biobyt(UK) Product and Services
2.3.5 Biobyt(UK) CD28(Antibody) Revenue, Gross Margin and Market Share (2018-2019)
2.4 Aviva Systems Biology Corporation(US)
2.4.1 Aviva Systems Biology Corporation(US) Details
2.4.2 Aviva Systems Biology Corporation(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Aviva Systems Biology Corporation(US) SWOT Analysis
2.4.4 Aviva Systems Biology Corporation(US) Product and Services
2.4.5 Aviva Systems Biology Corporation(US) CD28(Antibody) Revenue, Gross Margin and Market Share (2018-2019)
2.5 BioLegend(US)
2.5.1 BioLegend(US) Details
2.5.2 BioLegend(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 BioLegend(US) SWOT Analysis
2.5.4 BioLegend(US) Product and Services
2.5.5 BioLegend(US) CD28(Antibody) Revenue, Gross Margin and Market Share (2018-2019)
2.6 Boster Biological Technology(US)
2.6.1 Boster Biological Technology(US) Details
2.6.2 Boster Biological Technology(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Boster Biological Technology(US) SWOT Analysis
2.6.4 Boster Biological Technology(US) Product and Services
2.6.5 Boster Biological Technology(US) CD28(Antibody) Revenue, Gross Margin and Market Share (2018-2019)
2.7 Novus Biologicals(US)
2.7.1 Novus Biologicals(US) Details
2.7.2 Novus Biologicals(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Novus Biologicals(US) SWOT Analysis
2.7.4 Novus Biologicals(US) Product and Services
2.7.5 Novus Biologicals(US) CD28(Antibody) Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bioss Antibodies(US)
2.8.1 Bioss Antibodies(US) Details
2.8.2 Bioss Antibodies(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bioss Antibodies(US) SWOT Analysis
2.8.4 Bioss Antibodies(US) Product and Services
2.8.5 Bioss Antibodies(US) CD28(Antibody) Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bio-Rad(US)
2.9.1 Bio-Rad(US) Details
2.9.2 Bio-Rad(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bio-Rad(US) SWOT Analysis
2.9.4 Bio-Rad(US) Product and Services
2.9.5 Bio-Rad(US) CD28(Antibody) Revenue, Gross Margin and Market Share (2018-2019)
2.10 ProteoGenix(FR)
2.10.1 ProteoGenix(FR) Details
2.10.2 ProteoGenix(FR) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 ProteoGenix(FR) SWOT Analysis
2.10.4 ProteoGenix(FR) Product and Services
2.10.5 ProteoGenix(FR) CD28(Antibody) Revenue, Gross Margin and Market Share (2018-2019)
2.11 USBiological(US)
2.11.1 USBiological(US) Details
2.11.2 USBiological(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 USBiological(US) SWOT Analysis
2.11.4 USBiological(US) Product and Services
2.11.5 USBiological(US) CD28(Antibody) Revenue, Gross Margin and Market Share (2018-2019)
2.12 Rockland(US)
2.12.1 Rockland(US) Details
2.12.2 Rockland(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Rockland(US) SWOT Analysis
2.12.4 Rockland(US) Product and Services
2.12.5 Rockland(US) CD28(Antibody) Revenue, Gross Margin and Market Share (2018-2019)
2.13 ProSci(US)
2.13.1 ProSci(US) Details
2.13.2 ProSci(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 ProSci(US) SWOT Analysis
2.13.4 ProSci(US) Product and Services
2.13.5 ProSci(US) CD28(Antibody) Revenue, Gross Margin and Market Share (2018-2019)
2.14 St John’s Laboratory Ltd(UK)
2.14.1 St John’s Laboratory Ltd(UK) Details
2.14.2 St John’s Laboratory Ltd(UK) Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 St John’s Laboratory Ltd(UK) SWOT Analysis
2.14.4 St John’s Laboratory Ltd(UK) Product and Services
2.14.5 St John’s Laboratory Ltd(UK) CD28(Antibody) Revenue, Gross Margin and Market Share (2018-2019)
2.15 BethylLaboratories(US)
2.15.1 BethylLaboratories(US) Details
2.15.2 BethylLaboratories(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 BethylLaboratories(US) SWOT Analysis
2.15.4 BethylLaboratories(US) Product and Services
2.15.5 BethylLaboratories(US) CD28(Antibody) Revenue, Gross Margin and Market Share (2018-2019)
2.16 Thermo Fisher Scientific(US)
2.16.1 Thermo Fisher Scientific(US) Details
2.16.2 Thermo Fisher Scientific(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Thermo Fisher Scientific(US) SWOT Analysis
2.16.4 Thermo Fisher Scientific(US) Product and Services
2.16.5 Thermo Fisher Scientific(US) CD28(Antibody) Revenue, Gross Margin and Market Share (2018-2019)
2.17 ProteoGenix(FR)
2.17.1 ProteoGenix(FR) Details
2.17.2 ProteoGenix(FR) Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 ProteoGenix(FR) SWOT Analysis
2.17.4 ProteoGenix(FR) Product and Services
2.17.5 ProteoGenix(FR) CD28(Antibody) Revenue, Gross Margin and Market Share (2018-2019)
2.18 SouthernBiotech(US)
2.18.1 SouthernBiotech(US) Details
2.18.2 SouthernBiotech(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 SouthernBiotech(US) SWOT Analysis
2.18.4 SouthernBiotech(US) Product and Services
2.18.3 SouthernBiotech(US) CD28(Antibody) Revenue, Gross Margin and Market Share (2018-2019)
2.19 Genetex(US)
2.19.1 Genetex(US) Details
2.19.2 Genetex(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Genetex(US) SWOT Analysis
2.19.4 Genetex(US) Product and Services
2.19.5 Genetex(US) CD28(Antibody) Revenue, Gross Margin and Market Share (2018-2019)
2.20 R&D Systems(US)
2.20.1 R&D Systems(US) Details
2.20.2 R&D Systems(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 R&D Systems(US) SWOT Analysis
2.20.4 R&D Systems(US) Product and Services
2.20.5 R&D Systems(US) CD28(Antibody) Revenue, Gross Margin and Market Share (2018-2019)
2.21 Atlas Antibodies(SE)
2.21.1 Atlas Antibodies(SE) Details
2.21.2 Atlas Antibodies(SE) Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Atlas Antibodies(SE) SWOT Analysis
2.21.4 Atlas Antibodies(SE) Product and Services
2.21.5 Atlas Antibodies(SE) CD28(Antibody) Revenue, Gross Margin and Market Share (2018-2019)
2.22 BioVision(US)
2.22.1 BioVision(US) Details
2.22.2 BioVision(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.22.3 BioVision(US) SWOT Analysis
2.22.4 BioVision(US) Product and Services
2.22.5 BioVision(US) CD28(Antibody) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global CD28(Antibody) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 CD28(Antibody) Players Market Share
3.2.2 Top 10 CD28(Antibody) Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global CD28(Antibody) Revenue and Market Share by Regions
4.2 North America CD28(Antibody) Revenue and Growth Rate (2015-2020)
4.3 Europe CD28(Antibody) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific CD28(Antibody) Revenue and Growth Rate (2015-2020)
4.5 South America CD28(Antibody) Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa CD28(Antibody) Revenue and Growth Rate (2015-2020)
5 North America CD28(Antibody) Revenue by Countries
5.1 North America CD28(Antibody) Revenue by Countries (2015-2020)
5.2 USA CD28(Antibody) Revenue and Growth Rate (2015-2020)
5.3 Canada CD28(Antibody) Revenue and Growth Rate (2015-2020)
5.4 Mexico CD28(Antibody) Revenue and Growth Rate (2015-2020)
6 Europe CD28(Antibody) Revenue by Countries
6.1 Europe CD28(Antibody) Revenue by Countries (2015-2020)
6.2 Germany CD28(Antibody) Revenue and Growth Rate (2015-2020)
6.3 UK CD28(Antibody) Revenue and Growth Rate (2015-2020)
6.4 France CD28(Antibody) Revenue and Growth Rate (2015-2020)
6.5 Russia CD28(Antibody) Revenue and Growth Rate (2015-2020)
6.6 Italy CD28(Antibody) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific CD28(Antibody) Revenue by Countries
7.1 Asia-Pacific CD28(Antibody) Revenue by Countries (2015-2020)
7.2 China CD28(Antibody) Revenue and Growth Rate (2015-2020)
7.3 Japan CD28(Antibody) Revenue and Growth Rate (2015-2020)
7.4 Korea CD28(Antibody) Revenue and Growth Rate (2015-2020)
7.5 India CD28(Antibody) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia CD28(Antibody) Revenue and Growth Rate (2015-2020)
8 South America CD28(Antibody) Revenue by Countries
8.1 South America CD28(Antibody) Revenue by Countries (2015-2020)
8.2 Brazil CD28(Antibody) Revenue and Growth Rate (2015-2020)
8.3 Argentina CD28(Antibody) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue CD28(Antibody) by Countries
9.1 Middle East & Africa CD28(Antibody) Revenue by Countries (2015-2020)
9.2 Saudi Arabia CD28(Antibody) Revenue and Growth Rate (2015-2020)
9.3 UAE CD28(Antibody) Revenue and Growth Rate (2015-2020)
9.4 Egypt CD28(Antibody) Revenue and Growth Rate (2015-2020)
9.5 South Africa CD28(Antibody) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global CD28(Antibody) Revenue and Market Share by Type (2015-2020)
10.2 Global CD28(Antibody) Market Forecast by Type (2019-2024)
10.3 Above 90% Revenue Growth Rate (2015-2025)
10.4 Above 95% Revenue Growth Rate (2015-2025)
10.5 Above 99% Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global CD28(Antibody) Market Segment by Application
11.1 Global CD28(Antibody) Revenue Market Share by Application (2015-2020)
11.2 CD28(Antibody) Market Forecast by Application (2019-2024)
11.3 Biopharmaceutical Companies Revenue Growth (2015-2020)
11.4 Hospitals Revenue Growth (2015-2020)
11.5 Bioscience Research Institutions Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global CD28(Antibody) Market Size Forecast (2021-2025)
12.1 Global CD28(Antibody) Market Size Forecast (2021-2025)
12.2 Global CD28(Antibody) Market Forecast by Regions (2021-2025)
12.3 North America CD28(Antibody) Revenue Market Forecast (2021-2025)
12.4 Europe CD28(Antibody) Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific CD28(Antibody) Revenue Market Forecast (2021-2025)
12.6 South America CD28(Antibody) Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa CD28(Antibody) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global CD28(Antibody) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of CD28(Antibody) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global CD28(Antibody) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market CD28(Antibody) Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbexa Ltd(UK) Corporate Information, Location and Competitors
Table 6. Abbexa Ltd(UK) CD28(Antibody) Major Business
Table 7. Abbexa Ltd(UK) CD28(Antibody) Total Revenue (USD Million) (2017-2018)
Table 8. Abbexa Ltd(UK) SWOT Analysis
Table 9. Abbexa Ltd(UK) CD28(Antibody) Product and Solutions
Table 10. Abbexa Ltd(UK) CD28(Antibody) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Lifespan Biosciences(US) Corporate Information, Location and Competitors
Table 12. Lifespan Biosciences(US) CD28(Antibody) Major Business
Table 13. Lifespan Biosciences(US) CD28(Antibody) Total Revenue (USD Million) (2018-2019)
Table 14. Lifespan Biosciences(US) SWOT Analysis
Table 15. Lifespan Biosciences(US) CD28(Antibody) Product and Solutions
Table 16. Lifespan Biosciences(US) CD28(Antibody) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Biobyt(UK) Corporate Information, Location and Competitors
Table 18. Biobyt(UK) CD28(Antibody) Major Business
Table 19. Biobyt(UK) CD28(Antibody) Total Revenue (USD Million) (2017-2018)
Table 20. Biobyt(UK) SWOT Analysis
Table 21. Biobyt(UK) CD28(Antibody) Product and Solutions
Table 22. Biobyt(UK) CD28(Antibody) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Aviva Systems Biology Corporation(US) Corporate Information, Location and Competitors
Table 24. Aviva Systems Biology Corporation(US) CD28(Antibody) Major Business
Table 25. Aviva Systems Biology Corporation(US) CD28(Antibody) Total Revenue (USD Million) (2017-2018)
Table 26. Aviva Systems Biology Corporation(US) SWOT Analysis
Table 27. Aviva Systems Biology Corporation(US) CD28(Antibody) Product and Solutions
Table 28. Aviva Systems Biology Corporation(US) CD28(Antibody) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. BioLegend(US) Corporate Information, Location and Competitors
Table 30. BioLegend(US) CD28(Antibody) Major Business
Table 31. BioLegend(US) CD28(Antibody) Total Revenue (USD Million) (2017-2018)
Table 32. BioLegend(US) SWOT Analysis
Table 33. BioLegend(US) CD28(Antibody) Product and Solutions
Table 34. BioLegend(US) CD28(Antibody) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Boster Biological Technology(US) Corporate Information, Location and Competitors
Table 36. Boster Biological Technology(US) CD28(Antibody) Major Business
Table 37. Boster Biological Technology(US) CD28(Antibody) Total Revenue (USD Million) (2017-2018)
Table 38. Boster Biological Technology(US) SWOT Analysis
Table 39. Boster Biological Technology(US) CD28(Antibody) Product and Solutions
Table 40. Boster Biological Technology(US) CD28(Antibody) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Novus Biologicals(US) Corporate Information, Location and Competitors
Table 42. Novus Biologicals(US) CD28(Antibody) Major Business
Table 43. Novus Biologicals(US) CD28(Antibody) Total Revenue (USD Million) (2017-2018)
Table 44. Novus Biologicals(US) SWOT Analysis
Table 45. Novus Biologicals(US) CD28(Antibody) Product and Solutions
Table 46. Novus Biologicals(US) CD28(Antibody) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Bioss Antibodies(US) Corporate Information, Location and Competitors
Table 48. Bioss Antibodies(US) CD28(Antibody) Major Business
Table 49. Bioss Antibodies(US) CD28(Antibody) Total Revenue (USD Million) (2017-2018)
Table 50. Bioss Antibodies(US) SWOT Analysis
Table 51. Bioss Antibodies(US) CD28(Antibody) Product and Solutions
Table 52. Bioss Antibodies(US) CD28(Antibody) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Bio-Rad(US) Corporate Information, Location and Competitors
Table 54. Bio-Rad(US) CD28(Antibody) Major Business
Table 55. Bio-Rad(US) CD28(Antibody) Total Revenue (USD Million) (2017-2018)
Table 56. Bio-Rad(US) SWOT Analysis
Table 57. Bio-Rad(US) CD28(Antibody) Product and Solutions
Table 58. Bio-Rad(US) CD28(Antibody) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. ProteoGenix(FR) Corporate Information, Location and Competitors
Table 60. ProteoGenix(FR) CD28(Antibody) Major Business
Table 61. ProteoGenix(FR) CD28(Antibody) Total Revenue (USD Million) (2017-2018)
Table 62. ProteoGenix(FR) SWOT Analysis
Table 63. ProteoGenix(FR) CD28(Antibody) Product and Solutions
Table 64. ProteoGenix(FR) CD28(Antibody) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. USBiological(US) Corporate Information, Location and Competitors
Table 66. USBiological(US) CD28(Antibody) Major Business
Table 67. USBiological(US) CD28(Antibody) Total Revenue (USD Million) (2017-2018)
Table 68. USBiological(US) SWOT Analysis
Table 69. USBiological(US) CD28(Antibody) Product and Solutions
Table 70. USBiological(US) CD28(Antibody) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Rockland(US) Corporate Information, Location and Competitors
Table 72. Rockland(US) CD28(Antibody) Major Business
Table 73. Rockland(US) CD28(Antibody) Total Revenue (USD Million) (2017-2018)
Table 74. Rockland(US) SWOT Analysis
Table 75. Rockland(US) CD28(Antibody) Product and Solutions
Table 76. Rockland(US) CD28(Antibody) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. ProSci(US) Corporate Information, Location and Competitors
Table 78. ProSci(US) CD28(Antibody) Major Business
Table 79. ProSci(US) CD28(Antibody) Total Revenue (USD Million) (2017-2018)
Table 80. ProSci(US) SWOT Analysis
Table 81. ProSci(US) CD28(Antibody) Product and Solutions
Table 82. ProSci(US) CD28(Antibody) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. St John's Laboratory Ltd(UK) Corporate Information, Location and Competitors
Table 84. St John's Laboratory Ltd(UK) CD28(Antibody) Major Business
Table 85. St John's Laboratory Ltd(UK) CD28(Antibody) Total Revenue (USD Million) (2017-2018)
Table 86. St John's Laboratory Ltd(UK) SWOT Analysis
Table 87. St John's Laboratory Ltd(UK) CD28(Antibody) Product and Solutions
Table 88. St John's Laboratory Ltd(UK) CD28(Antibody) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. BethylLaboratories(US) Corporate Information, Location and Competitors
Table 90. BethylLaboratories(US) CD28(Antibody) Major Business
Table 91. BethylLaboratories(US) CD28(Antibody) Total Revenue (USD Million) (2017-2018)
Table 92. BethylLaboratories(US) SWOT Analysis
Table 93. BethylLaboratories(US) CD28(Antibody) Product and Solutions
Table 94. BethylLaboratories(US) CD28(Antibody) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Thermo Fisher Scientific(US) Corporate Information, Location and Competitors
Table 96. Thermo Fisher Scientific(US) CD28(Antibody) Major Business
Table 97. Thermo Fisher Scientific(US) CD28(Antibody) Total Revenue (USD Million) (2017-2018)
Table 98. Thermo Fisher Scientific(US) SWOT Analysis
Table 99. Thermo Fisher Scientific(US) CD28(Antibody) Product and Solutions
Table 100. Thermo Fisher Scientific(US) CD28(Antibody) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. ProteoGenix(FR) Corporate Information, Location and Competitors
Table 102. ProteoGenix(FR) CD28(Antibody) Major Business
Table 103. ProteoGenix(FR) CD28(Antibody) Total Revenue (USD Million) (2017-2018)
Table 104. ProteoGenix(FR) SWOT Analysis
Table 105. ProteoGenix(FR) CD28(Antibody) Product and Solutions
Table 106. ProteoGenix(FR) CD28(Antibody) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. SouthernBiotech(US) CD28(Antibody) Type and Application
Table 108. SouthernBiotech(US) CD28(Antibody) Major Business
Table 109. SouthernBiotech(US) CD28(Antibody) Total Revenue (USD Million) (2017-2018)
Table 110. SouthernBiotech(US) SWOT Analysis
Table 111. SouthernBiotech(US) CD28(Antibody) Product and Solutions
Table 112. SouthernBiotech(US) CD28(Antibody) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. Genetex(US) Corporate Information, Location and Competitors
Table 114. Genetex(US) CD28(Antibody) Major Business
Table 115. Genetex(US) CD28(Antibody) Total Revenue (USD Million) (2017-2018)
Table 116. Genetex(US) SWOT Analysis
Table 117. Genetex(US) CD28(Antibody) Product and Solutions
Table 118. Genetex(US) CD28(Antibody) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. R&D Systems(US) Corporate Information, Location and Competitors
Table 120. R&D Systems(US) CD28(Antibody) Major Business
Table 121. R&D Systems(US) CD28(Antibody) Total Revenue (USD Million) (2017-2018)
Table 122. R&D Systems(US) SWOT Analysis
Table 123. R&D Systems(US) CD28(Antibody) Product and Solutions
Table 124. R&D Systems(US) CD28(Antibody) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 125. Atlas Antibodies(SE) Corporate Information, Location and Competitors
Table 126. Atlas Antibodies(SE) CD28(Antibody) Major Business
Table 127. Atlas Antibodies(SE) CD28(Antibody) Total Revenue (USD Million) (2017-2018)
Table 128. Atlas Antibodies(SE) SWOT Analysis
Table 129. Atlas Antibodies(SE) CD28(Antibody) Product and Solutions
Table 130. Atlas Antibodies(SE) CD28(Antibody) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 131. BioVision(US) Corporate Information, Location and Competitors
Table 132. BioVision(US) CD28(Antibody) Major Business
Table 133. BioVision(US) CD28(Antibody) Total Revenue (USD Million) (2017-2018)
Table 134. BioVision(US) SWOT Analysis
Table 135. BioVision(US) CD28(Antibody) Product and Solutions
Table 136. BioVision(US) CD28(Antibody) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 137. Global CD28(Antibody) Revenue (Million USD) by Players (2015-2020)
Table 138. Global CD28(Antibody) Revenue Share by Players (2015-2020)
Table 139. Global CD28(Antibody) Revenue (Million USD) by Regions (2015-2020)
Table 140. Global CD28(Antibody) Revenue Market Share by Regions (2015-2020)
Table 141. North America CD28(Antibody) Revenue by Countries (2015-2020)
Table 142. North America CD28(Antibody) Revenue Market Share by Countries (2015-2020)
Table 143. Europe CD28(Antibody) Revenue (Million USD) by Countries (2015-2020)
Table 144. Asia-Pacific CD28(Antibody) Revenue (Million USD) by Countries (2015-2020)
Table 145. South America CD28(Antibody) Revenue by Countries (2015-2020)
Table 146. South America CD28(Antibody) Revenue Market Share by Countries (2015-2020)
Table 147. Middle East and Africa CD28(Antibody) Revenue (Million USD) by Countries (2015-2020)
Table 148. Middle East and Africa CD28(Antibody) Revenue Market Share by Countries (2015-2020)
Table 149. Global CD28(Antibody) Revenue (Million USD) by Type (2015-2020)
Table 150. Global CD28(Antibody) Revenue Share by Type (2015-2020)
Table 151. Global CD28(Antibody) Revenue Forecast by Type (2021-2025)
Table 152. Global CD28(Antibody) Revenue by Application (2015-2020)
Table 153. Global CD28(Antibody) Revenue Share by Application (2015-2020)
Table 154. Global CD28(Antibody) Revenue Forecast by Application (2021-2025)
Table 155. Global CD28(Antibody) Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. CD28(Antibody) Picture
Figure 2. Global CD28(Antibody) Revenue Market Share by Type in 2019
Figure 3. Above 90% Picture
Figure 4. Above 95% Picture
Figure 5. Above 99% Picture
Figure 6. Others Picture
Figure 7. CD28(Antibody) Revenue Market Share by Application in 2019
Figure 8. Biopharmaceutical Companies Picture
Figure 9. Hospitals Picture
Figure 10. Bioscience Research Institutions Picture
Figure 11. Others Picture
Figure 12. Global CD28(Antibody) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America CD28(Antibody) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe CD28(Antibody) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific CD28(Antibody) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America CD28(Antibody) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa CD28(Antibody) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global CD28(Antibody) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global CD28(Antibody) Revenue Share by Players in 2019
Figure 20. Global Top 5 Players CD28(Antibody) Revenue Market Share in 2019
Figure 21. Global Top 10 Players CD28(Antibody) Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global CD28(Antibody) Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global CD28(Antibody) Revenue Market Share by Regions (2015-2020)
Figure 25. Global CD28(Antibody) Revenue Market Share by Regions in 2018
Figure 26. North America CD28(Antibody) Revenue and Growth Rate (2015-2020)
Figure 27. Europe CD28(Antibody) Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific CD28(Antibody) Revenue and Growth Rate (2015-2020)
Figure 29. South America CD28(Antibody) Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa CD28(Antibody) Revenue and Growth Rate (2015-2020)
Figure 31. North America CD28(Antibody) Revenue Market Share by Countries (2015-2020)
Figure 32. North America CD28(Antibody) Revenue Market Share by Countries in 2019
Figure 33. USA CD28(Antibody) Revenue and Growth Rate (2015-2020)
Figure 34. Canada CD28(Antibody) Revenue and Growth Rate (2015-2020)
Figure 35. Mexico CD28(Antibody) Revenue and Growth Rate (2015-2020)
Figure 36. Europe CD28(Antibody) Revenue Market Share by Countries (2015-2020)
Figure 37. Europe CD28(Antibody) Revenue Market Share by Countries in 2019
Figure 38. Germany CD28(Antibody) Revenue and Growth Rate (2015-2020)
Figure 39. UK CD28(Antibody) Revenue and Growth Rate (2015-2020)
Figure 40. France CD28(Antibody) Revenue and Growth Rate (2015-2020)
Figure 41. Russia CD28(Antibody) Revenue and Growth Rate (2015-2020)
Figure 42. Italy CD28(Antibody) Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific CD28(Antibody) Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific CD28(Antibody) Revenue Market Share by Countries in 2019
Figure 45. China CD28(Antibody) Revenue and Growth Rate (2015-2020)
Figure 46. Japan CD28(Antibody) Revenue and Growth Rate (2015-2020)
Figure 47. Korea CD28(Antibody) Revenue and Growth Rate (2015-2020)
Figure 48. India CD28(Antibody) Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia CD28(Antibody) Revenue and Growth Rate (2015-2020)
Figure 50. South America CD28(Antibody) Revenue Market Share by Countries (2015-2020)
Figure 51. South America CD28(Antibody) Revenue Market Share by Countries in 2019
Figure 52. Brazil CD28(Antibody) Revenue and Growth Rate (2015-2020)
Figure 53. Argentina CD28(Antibody) Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa CD28(Antibody) Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa CD28(Antibody) Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia CD28(Antibody) Revenue and Growth Rate (2015-2020)
Figure 57. UAE CD28(Antibody) Revenue and Growth Rate (2015-2020)
Figure 58. Egypt CD28(Antibody) Revenue and Growth Rate (2015-2020)
Figure 59. South Africa CD28(Antibody) Revenue and Growth Rate (2015-2020)
Figure 60. Global CD28(Antibody) Revenue Share by Type (2015-2020)
Figure 61. Global CD28(Antibody) Revenue Share by Type in 2019
Figure 62. Global CD28(Antibody) Market Share Forecast by Type (2021-2025)
Figure 63. Global Above 90% Revenue Growth Rate (2015-2020)
Figure 64. Global Above 95% Revenue Growth Rate (2015-2020)
Figure 65. Global Above 99% Revenue Growth Rate (2015-2020)
Figure 66. Global Others Revenue Growth Rate (2015-2020)
Figure 67. Global CD28(Antibody) Revenue Share by Application (2015-2020)
Figure 68. Global CD28(Antibody) Revenue Share by Application in 2019
Figure 69. Global CD28(Antibody) Market Share Forecast by Application (2021-2025)
Figure 70. Global Biopharmaceutical Companies Revenue Growth Rate (2015-2020)
Figure 71. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 72. Global Bioscience Research Institutions Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global CD28(Antibody) Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global CD28(Antibody) Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global CD28(Antibody) Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America CD28(Antibody) Revenue Market Forecast (2021-2025)
Figure 78. Europe CD28(Antibody) Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific CD28(Antibody) Revenue Market Forecast (2021-2025)
Figure 80. South America CD28(Antibody) Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa CD28(Antibody) Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel

---